The CDSCO's latest inspections revealed that 84 batches of commonly used drugs, including steroids and cholesterol reducers, did not meet quality standards. The apex body regularly identifies and removes such drugs from the market to ensure safety. New guidelines for sample collection have been introduced to streamline the process.